synNotch-programmed iPSC-derived NK cells usurp TIGIT and CD73 activities for glioblastoma therapy
Kyle B. Lupo(Memorial Sloan Kettering Cancer Center), Sandro Matosevic(Purdue University West Lafayette)
Cited by 39
Related Papers
Engineered natural killer cells impede the immunometabolic CD73-adenosine axis in solid tumors
|eLife|2022|33
Engineered natural killer cells impede the immunometabolic CD73-adenosine axis in solid tumors
|bioRxiv (Cold Spring Harbor Laboratory)|2021|2
Engineered NKG2C <sup>+</sup> NK-like T cells exhibit superior antitumor efficacy while mitigating cytokine release syndrome
|bioRxiv (Cold Spring Harbor Laboratory)|2024|2